Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

2010 - Updates & Insights Blog

    • Director's Note - July 2010
      , by Daniela S. Gerhard, Ph.D.

      The HIV+ Tumor Molecular Characterization Project (H+TMCP) is a new initiative with the goal of understanding the effect of HIV infection on the development of certain cancers. Center for Cancer Genomics scientific leader Dr. Daniela Gerhard remarks on the opportunities addressed by this program and the general need for progress on HIV research.

      Continue Reading >

    • NCI's Cancer Target Discovery and Development (C-T-D-Squared) Program
      New Program Highlights: The CTD² Network and CGCI

      CCG manages many programs aiming to enhance our understanding of the molecular mechanisms of cancer. The Cancer Target Discovery and Development (CTD2) Network is a new initiative tasked to bridge the gap between cancer genomics and precision oncology and the Cancer Genomic Characterization Initiative (CGCI) focuses on characterizing pediatric and rare adult cancers. In 2010, these programs were managed by CCG's then Office of Cancer Genomics.

      Continue Reading >

    • Recovery Act Funds Accelerate Cancer Genomics Research
      , by Center for Cancer Genomics Staff

      The National Cancer Institute (NCI) has invested a significant portion of its American Recovery and Reinvestment Act (ARRA) funds in existing cancer genomics research programs, including The Cancer Genome Atlas (TCGA)

      Continue Reading >

    • Director's Note - March 2010
      , by Daniela S. Gerhard, Ph.D.

      A 2010 note from Dr. Daniela Gerhard, Director of the Office of Cancer Genomics (OCG), then a part of the Center for Cancer Genomics. The letter welcomes cancer genomics researchers to learn about the goals and many projects of OCG.

      Continue Reading >

Archive

Email